Select Cognition Coverage and Published Editorials
Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients
Genetic Engineering & Biotechnology News
By Alex Philippidis
November 5, 2024
For People with Alzheimer Disease, Treatment with an Experimental, Oral Small Molecule was Linked to Significant Slowing in Cognitive Decline
Practical Neurology
November 1, 2024
Refining Alzheimer Treatment Through Biomarker-Based Patient Selection: Michael Woodward, MD, FRACP; Anthony Caggiano, MD, PhD
Neurology Live
By Isabella Ciccone, MPH
October 31, 2024
Their Alzheimer’s treatment worked — but shares fell anyway
PharmaVoice
By Michael Gibney
Aug. 29, 2024
Small molecule oligomer antagonist for Alzheimer’s disease boosts brain connectivity
Healio Neurology
By Shenaz Bagha
August 27, 2024
CT1812 slows cognitive decline in proof-of-concept clinical trial
Alzheimer’s News Today
By Marisa Wexler
August 23, 2024